Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors

NCT07431489 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma
MEK Inhibitor-Associated Retinopathy

Interventions

OTHER: Ophthalmologic Retinal Monitoring During BRAF/MEK Inhibitor Therapy

Sponsor

Institute of Oncology Ljubljana